Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. [electronic resource]
Producer: 20080429Description: S19-25 p. digitalISSN:- 0275-004X
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Female
- Humans
- Infant
- Infant, Low Birth Weight
- Infant, Newborn
- Infant, Premature
- Injections
- Male
- Prospective Studies
- Retinopathy of Prematurity -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.